D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
TechTarget
TTGT
$275M
| $6.84M | 0.01% |
196,200
+6,025
| +3% | +$178K |
|
1527
Nomura Holdings
NMR
$28.6B
| $6.82M | 0.01% |
1,512,580
+711,292
| +89% | +$2.93M |
|
1528
Prestige Consumer Healthcare
PBH
$2.39B
| $6.82M | 0.01% |
111,373
-14,018
| -11% | -$832K |
|
1529
Lear
LEA
$7.26B
| $6.82M | 0.01% |
48,284
-23,709
| -33% | -$3.18M |
|
1530
Collegium Pharmaceutical
COLL
$1.15B
| $6.82M | 0.01% |
221,505
+76,353
| +53% | +$1.91M |
|
1531
Donaldson
DCI
$10.8B
| $6.82M | 0.01% |
104,305
+11,142
| +12% | +$679K |
|
1532
Cirrus Logic
CRUS
$6.87B
| $6.79M | 0.01% |
81,641
-24,604
| -23% | -$1.84M |
|
1533
PUT
Arthur J. Gallagher & Co
AJG
$65.1B
| $6.79M | 0.01% |
+30,200
| New | +$7.15M |
|
1534
CALL
Twilio
TWLO
$29.5B
| $6.78M | 0.01% |
89,300
-236,900
| -73% | -$14.8M |
|
1535
NMI Holdings
NMIH
$3.27B
| $6.74M | 0.01% |
226,949
+89,127
| +65% | +$2.49M |
|
1536
Dycom Industries
DY
$12.7B
| $6.72M | 0.01% |
58,416
+4,981
| +9% | +$473K |
|
1537
MakeMyTrip
MMYT
$4.97B
| $6.72M | 0.01% |
143,011
-37,628
| -21% | -$1.59M |
|
|
VSXY
1538
PUT
Victoria's Secret
VSXY
$6.78B
| $6.71M | 0.01% |
253,000
+119,200
| +89% | +$2.53M |
|
1539
CALL
Freshpet
FRPT
$2.92B
| $6.71M | 0.01% |
77,300
| – | – |
|
1540
PUT
Merck
MRK
$323B
| $6.7M | 0.01% |
61,500
-134,900
| -69% | -$14M |
|
1541
Howard Hughes
HHH
$3.93B
| $6.7M | 0.01% |
82,199
+40,674
| +98% | +$2.85M |
|
1542
MillerKnoll
MLKN
$1.54B
| $6.7M | 0.01% |
251,187
-138,489
| -36% | -$3.53M |
|
1543
Kennametal
KMT
$2.69B
| $6.7M | 0.01% |
259,836
-43,519
| -14% | -$1.05M |
|
1544
Cousins Properties
CUZ
$5.28B
| $6.7M | 0.01% |
275,112
-222,364
| -45% | -$4.56M |
|
1545
PUT
STMicroelectronics
STM
$47.7B
| $6.69M | 0.01% |
133,500
+57,400
| +75% | +$2.57M |
|
1546
CALL
TransDigm Group
TDG
$71.9B
| $6.68M | 0.01% |
6,600
-10,500
| -61% | -$9.69M |
|
1547
PUT
Ambarella
AMBA
$2.99B
| $6.67M | 0.01% |
108,800
| – | – |
|
1548
Extreme Networks
EXTR
$3.92B
| $6.66M | 0.01% |
377,355
-216,015
| -36% | -$4.08M |
|
1549
Vertex
VERX
$2.05B
| $6.65M | 0.01% |
246,971
+214,824
| +668% | +$5.51M |
|
1550
Rambus
RMBS
$10.4B
| $6.65M | 0.01% |
97,431
-109,879
| -53% | -$6.84M |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.